Your browser doesn't support javascript.
loading
Immediate versus staged revascularisation of non-culprit arteries in patients with acute coronary syndrome: a systematic review and meta-analysis.
Vriesendorp, P A; Wilschut, J M; Diletti, R; Daemen, J; Kardys, I; Zijlstra, F; Van Mieghem, N M; Bennett, J; Esposito, G; Sabate, M; den Dekker, W K.
Afiliación
  • Vriesendorp PA; Department of Cardiology, Thoraxcenter, Erasmus University Medical Centre, Rotterdam, The Netherlands.
  • Wilschut JM; The Heart Centre, The Alfred Hospital, Melbourne, Australia.
  • Diletti R; Department of Cardiology, Thoraxcenter, Erasmus University Medical Centre, Rotterdam, The Netherlands.
  • Daemen J; Department of Cardiology, Thoraxcenter, Erasmus University Medical Centre, Rotterdam, The Netherlands.
  • Kardys I; Department of Cardiology, Thoraxcenter, Erasmus University Medical Centre, Rotterdam, The Netherlands.
  • Zijlstra F; Department of Cardiology, Thoraxcenter, Erasmus University Medical Centre, Rotterdam, The Netherlands.
  • Van Mieghem NM; Department of Cardiology, Thoraxcenter, Erasmus University Medical Centre, Rotterdam, The Netherlands.
  • Bennett J; Department of Cardiology, Thoraxcenter, Erasmus University Medical Centre, Rotterdam, The Netherlands.
  • Esposito G; Department of Cardiovascular Medicine, University Hospitals Leuven, Leuven, Belgium.
  • Sabate M; Division of Cardiology, Department of Advanced Biomedical Sciences, University of Naples Federico II, Naples, Italy.
  • den Dekker WK; Cardiovascular Institute, Hospital Clinic, IDIBAPS, University of Barcelona, Barcelona, Spain.
Neth Heart J ; 30(10): 449-456, 2022 Oct.
Article en En | MEDLINE | ID: mdl-35536483
ABSTRACT
Although there is robust evidence that revascularisation of non-culprit vessels should be pursued in patients presenting with an acute coronary syndrome (ACS) and multivessel coronary artery disease (MVD), the optimal timing of complete revascularisation remains disputed. In this systematic review and meta-analysis our results suggest that outcomes are comparable for immediate and staged complete revascularisation in patients with ACS and MVD. However, evidence from randomised controlled trials remains scarce and cautious interpretation of these results is recommended. More non-biased evidence is necessary to aid future decision making on the optimal timing of complete revascularisation.
Palabras clave

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Tipo de estudio: Clinical_trials / Systematic_reviews Idioma: En Revista: Neth Heart J Año: 2022 Tipo del documento: Article País de afiliación: Países Bajos

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Tipo de estudio: Clinical_trials / Systematic_reviews Idioma: En Revista: Neth Heart J Año: 2022 Tipo del documento: Article País de afiliación: Países Bajos